Shareholder Votes

Monte Rosa Therapeutics, Inc. shareholders approved Election of three Class II directors: Andrew Schiff, M.D., Chandra P. Leo, M.D. and Anthony Manning, Ph.D. at the 2026-06-11 meeting.

“The stockholders of the Company elected Andrew Schiff, M.D., Chandra P. Leo, M.D. and Anthony Manning, Ph.D. as Class II directors of the Company, for a three-year term ending at the annual meeting of stockholders to be held in 2029 and until their successors have been duly elected and qualified or until their earlier resignation or removal.”

Compass Therapeutics, Inc. shareholders approved Non-binding, Advisory Vote on the Holding of the Future Advisory Votes on the Compensation of our Named Executive Officers at the 2026-06-10 meeting.

“Proposal No. 4. Non-binding, Advisory Vote on the Holding of the Future Advisory Votes on the Compensation of our Named Executive Officers. The stockholders voted, on a non-binding, advisory basis, to hold such advisory votes annually, by the votes set forth in the table below: Every Year Every Two Years Every Three Years Abstain 118,289,260 811,275 1,491,631 1,229,517”

Compass Therapeutics, Inc. shareholders approved Non-binding, Advisory Vote on the Compensation of our Named Executive Officers at the 2026-06-10 meeting.

“Proposal No. 3. Non-binding, Advisory Vote on the Compensation of our Named Executive Officers. The stockholders voted to approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, by the votes set forth in the table below: For Against Abstain Broker Non-votes 117,963,684 1,796,022 2,061,977 21,320,318”

Compass Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm (CohnReznick, LLP) at the 2026-06-10 meeting.

“Proposal No. 2. Ratification of Appointment of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of CohnReznick, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026, by the votes set forth in the table below: For Against Withheld Broker Non-votes 137,896,097 181,037 5,064,867 -”

Compass Therapeutics, Inc. shareholders approved Election of two Class III nominees for director at the 2026-06-10 meeting.

“Proposal No. 1. Election of Directors. The stockholders elected the two Class III nominees for director to serve until the Company’s 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, by the votes set forth in the table below: Name For Withheld Broker Non-votes Thomas J. Schuetz, M.D., Ph.D. 102,984,184 18,837,499 21,320,318 Richard S. Lindahl, M.B.A. 103,453,540 18,368,143 21,320,318”

PRIMEENERGY RESOURCES CORP shareholders approved Election of five directors for a one-year term at the 2026-06-10 meeting.

“Vote Details Beverly A. Cummings For 944,561 Withheld 279,464 Charles E. Drimal, Jr. For 1,030,664 Withheld 193,361 Thomas S. T. Gimbel For 1,195,211 Withheld 28,814 Clint Hurt For 1,151,942 Withheld 72,083 H. Gifford Fong For 1,178,957 Withheld 45,068”

22nd Century Group, Inc. shareholders approved Ratification of WithumSmith+Brown, PC as independent registered public accountants for 2026 at the 2026-06-11 meeting.

“Proposal Three : To ratify the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accountants for 2026.”

22nd Century Group, Inc. shareholders approved Advisory resolution approving executive compensation for fiscal year 2025 at the 2026-06-11 meeting.

“Proposal Two : To approve an advisory resolution approving executive compensation for fiscal year 2025.”

22nd Century Group, Inc. shareholders approved Election of Lucille Salhany as a Class III director at the 2026-06-11 meeting.

“Proposal One : To elect Lucille Salhany as a Class III director to serve until the 2029 annual meeting of the stockholders and until her respective successor has been elected and qualified.”

Bluerock Homes Trust, Inc. shareholders approved Ratification of Grant Thornton LLP as independent registered public accounting firm at the 2026-06-10 meeting.

“The stockholders ratified Grant Thornton LLP as the Company’s independent registered public accounting firm for 2026: For 3,482,471 Against 96,962 Abstain 64,133”

Bluerock Homes Trust, Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“The following five persons were elected to serve as directors of the Company:”

AIRGAIN INC shareholders approved Approval of the amendment and restatement of 2016 Incentive Award Plan. at the 2026-06-10 meeting.

“Proposal 4 – To approve the amendment and restatement of 2016 Incentive Award Plan. For Against Abstain Broker Non-Votes 3,356,979 2,585,543 92,244 4,158,525”

AIRGAIN INC shareholders approved Advisory vote on the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. at the 2026-06-10 meeting.

“Proposal 3 – To consider and vote upon, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. For Against Abstain Broker Non-Votes 3,667,041 2,275,810 91,915 4,158,525”

AIRGAIN INC shareholders approved Ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-10 meeting.

“Proposal 2 – To consider and vote upon the ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain Broker Non-Votes 9,948,940 239,129 5,222 —”

AIRGAIN INC shareholders approved Election of two Class I directors for a three-year term to expire at the 2029 Annual Meeting of Stockholders. at the 2026-06-10 meeting.

“Proposal 1 – To elect two directors to serve as Class I directors for a three-year term to expire at the 2029 Annual Meeting of Stockholders. Nominee For Withheld Broker Non-Votes James K. Sims 2,761,190 3,273,576 4,158,525 Tzau-Jin Chung 3,187,644 2,847,122 4,158,525”

Triller Group Inc. shareholders approved Approval of, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of common stock (or securities convertible into or exercisable for common stock) in one or more private placements in excess of 20% of our outstanding common stock. at the 2026-06-10 meeting.

“Shareholders approved, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of common stock (or securities convertible into or exercisable for common stock) in one or more private placements including a potential private investment in public equity (“PIPE”) financing of up to $300 million.”

Triller Group Inc. shareholders approved Approval of the Triller Group Inc. 2026 Equity Incentive Plan, including the reservation of 39,600,000 shares of Common Stock for issuance thereunder. at the 2026-06-10 meeting.

“Shareholders approved the Triller Group Inc. 2026 Equity Incentive Plan, including the reservation of 39,600,000 shares of Common Stock for issuance thereunder.”

Triller Group Inc. shareholders approved Approval of an amendment to the Company’s Certificate of Incorporation to change the name of the Company from "Triller Group Inc." to "Eight Holdings Inc." at the 2026-06-10 meeting.

“Shareholders approved an amendment to the Company’s Certificate of Incorporation to change the name of the Company from “Triller Group Inc.” to “Eight Holdings Inc.””

Triller Group Inc. shareholders approved Approval of an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of our common stock by a ratio of no more than 1-for-10 at any time within one year after the 2025 Annual Meeting, with the exact ratio to be determined within this range as determined by the Board at the 2026-06-10 meeting.

“Shareholders approved an amendment to the Company’s Certificate of Incorporation (the “Certificate of Incorporation”) to effect a reverse stock split of our common stock, par value $0.001 per share (the “Common Stock”) by a ratio of no more than 1-for-10 at any time within one year after the 2025 Annual Meeting, with the exact ratio to be determined within this range as determined by the Board in its sole discretion.”

Triller Group Inc. shareholders approved Ratification of the Company’s Independent Auditors at the 2026-06-10 meeting.

“Shareholders ratified the appointment of Enrome LLP as the independent auditors of the Company for the fiscal year ended December 31, 2025, in accordance with the voting results listed below.”

Triller Group Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“All of the following four nominees were elected to the Company’s Board of Directors, in accordance with the voting results listed below, to serve until the next Annual Meeting and until their successors have been duly elected and have qualified.”

Custom Truck One Source, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“In accordance with the voting results listed below, the appointment of Ernst & Young LLP was ratified by stockholders. For Against Abstain 209,767,213 41,309 733,257”

Custom Truck One Source, Inc. shareholders approved Election of three Class A directors to serve until the 2029 annual meeting at the 2026-06-11 meeting.

“In accordance with the voting results listed below, each of the nominees was elected as a Class A director. Nominee For Withheld Broker Non-Votes Paul Bader 178,245,358 23,142,056 9,154,365”

TJX COMPANIES INC /DE/ shareholders approved Advisory vote on executive compensation (say-on-pay) at the 2026-06-09 meeting.

“On an advisory basis, the compensation paid to the Company’s named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion (the say-on-pay vote), was approved.”

TJX COMPANIES INC /DE/ shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal 2027 at the 2026-06-09 meeting.

“The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2027 was ratified.”

TJX COMPANIES INC /DE/ shareholders approved Election of Directors at the 2026-06-09 meeting.

“The annual meeting of shareholders of The TJX Companies, Inc. (the “Company”) was held on June 9, 2026 . The final voting results of the annual meeting are as follows: Proposal 1 : Each nominee for director was elected, each to serve until the next annual meeting of shareholders and until his or her successor is duly elected and qualified.”

HUDSON TECHNOLOGIES INC /NY shareholders approved Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“ratified the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026”

HUDSON TECHNOLOGIES INC /NY shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers at the 2026-06-10 meeting.

“approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers”

HUDSON TECHNOLOGIES INC /NY shareholders approved Election of Loan N. Mansy, Richard Parrillo, Eric A. Prouty and Alan Sheriff to serve as directors at the 2026-06-10 meeting.

“At the Annual Meeting of Shareholders of Hudson Technologies, Inc. (the “Company”) held on June 10, 2026, the shareholders of the Company: (i) elected Loan N. Mansy, Richard Parrillo, Eric A. Prouty and Alan Sheriff to serve as directors”

LivaNova PLC shareholders approved Approve share repurchase contracts and authorize entry into repurchase contracts with approved counterparties at the 2026-06-10 meeting.

“6. Ordinary resolution to approve, for the purposes of section 694 of the Companies Act, the terms of the proposed share repurchase contracts set out in Appendix A and Appendix B of the Proxy Statement (the “Share Repurchase Contracts”) and to authorize the Company to enter into a Share Repurchase Contract with any of the Approved Counterparties (as defined in the Proxy Statement)”

LivaNova PLC shareholders approved Disapply pre-emption rights for allotment of shares under section 570 of the Companies Act at the 2026-06-10 meeting.

“Votes For Votes Against Votes Abstained Broker Non-Votes 50,660,968 881,748 122,591 — 6. Ordinary resolution to approve, for the purposes of section 694 of the Companies Act, the terms of the proposed share repurchase contracts set out in Appendix A and Appendix B of the Proxy Statement (the “Share Repurchase Contracts”) and to authorize the Company to enter into a Share Repurchase Contract with any of the Approved Counterparties (as defined in the Proxy Statement) provided that: (A) the maximum aggregate number of Ordinary Shares that may be purchased pursuant to the Share Repurchase Contracts shall not exceed 10% of the total issued Ordinary Shares of the Company as at 5:00 pm Eastern Time on April 13, 2026 as adjusted on a proportionate basis to take into account any consolidation or division of shares from time to time; and (B) (unless previously revoked, varied or renewed by the Com”

LivaNova PLC shareholders approved Authorize directors to allot shares under section 551 of the Companies Act at the 2026-06-10 meeting.

“Votes For Votes Against Votes Abstained Broker Non-Votes 51,098,550 444,170 122,587 — 5. Special resolution subject to the passing of resolution 4 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 4, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders’ pre-emption rights) did not apply to any such allotment or sale, provided that this power is limited to the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of £10,985,296 , provided that: (A) (unless previously revoked, varied, or renewed by the Company) t”

LivaNova PLC shareholders approved Ratify appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026 at the 2026-06-10 meeting.

“3. Ordinary resolution to ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership (“PwC-U.S.”), as the Company’s independent registered public accounting firm for 2026. Votes For Votes Against Votes Abstained Broker Non-Votes 51,221,138 414,830 29,339 —”

LivaNova PLC shareholders approved Advisory vote on named executive officer compensation (U.S. Say on Pay) at the 2026-06-10 meeting.

“2. Ordinary resolution to approve, on an advisory basis, the Company’s compensation of its named executive officers (“U.S. Say on Pay”). Votes For Votes Against Votes Abstained Broker Non-Votes 49,311,078 499,536 18,225 1,836,468”

LivaNova PLC shareholders approved Elect Donald Zurbay as director at the 2026-06-10 meeting.

“Mr. Donald Zurbay Votes For Votes Against Votes Abstained Broker Non-Votes 49,714,058 96,890 17,891 1,836,468”

LivaNova PLC shareholders approved Elect Peter Wilver as director at the 2026-06-10 meeting.

“Mr. Peter Wilver Votes For Votes Against Votes Abstained Broker Non-Votes 49,647,347 161,581 19,911 1,836,468”

LivaNova PLC shareholders approved Elect Brooke Story as director at the 2026-06-10 meeting.

“Ms. Brooke Story Votes For Votes Against Votes Abstained Broker Non-Votes 49,349,241 462,872 16,726 1,836,468”

LivaNova PLC shareholders approved Elect Todd Schermerhorn as director at the 2026-06-10 meeting.

“Mr. Todd Schermerhorn Votes For Votes Against Votes Abstained Broker Non-Votes 49,508,349 302,599 17,891 1,836,468”

LivaNova PLC shareholders approved Elect Susan Podlogar as director at the 2026-06-10 meeting.

“Ms. Susan Podlogar Votes For Votes Against Votes Abstained Broker Non-Votes 49,676,374 138,263 14,202 1,836,468”

LivaNova PLC shareholders approved Elect Jette Nygaard-Andersen as director at the 2026-06-10 meeting.

“Ms. Jette Nygaard-Andersen Votes For Votes Against Votes Abstained Broker Non-Votes 49,714,402 97,584 16,853 1,836,468”

LivaNova PLC shareholders approved Elect Vladimir Makatsaria as director at the 2026-06-10 meeting.

“Mr. Vladimir Makatsaria Votes For Votes Against Votes Abstained Broker Non-Votes 49,712,270 102,361 14,208 1,836,468”

LivaNova PLC shareholders approved Elect William A. Kozy as director at the 2026-06-10 meeting.

“Mr. William A. Kozy Votes For Votes Against Votes Abstained Broker Non-Votes 49,471,660 340,680 16,499 1,836,468”

LivaNova PLC shareholders approved Elect Stacy Enxing Seng as director at the 2026-06-10 meeting.

“Ms. Stacy Enxing Seng Votes For Votes Against Votes Abstained Broker Non-Votes 49,343,880 470,546 14,413 1,836,468”

LivaNova PLC shareholders approved Elect Francesco Bianchi as director at the 2026-06-10 meeting.

“Mr. Francesco Bianchi Votes For Votes Against Votes Abstained Broker Non-Votes 49,294,527 517,219 17,093 1,836,468”

LivaNova PLC shareholders approved Elect J. Christopher Barry as director at the 2026-06-10 meeting.

“Mr. J. Christopher Barry Votes For Votes Against Votes Abstained Broker Non-Votes 49,450,193 360,942 17,704 1,836,468”

Ovid Therapeutics Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-10 meeting.

“Proposal 3 : The Company’s stockholders ratified the selection of KPMG LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the votes set forth in the table below: For Against Abstain Broker Non-Votes 130,845,667 32,505 80,756 N/A”

Ovid Therapeutics Inc. shareholders approved Advisory vote on compensation paid to named executive officers at the 2026-06-10 meeting.

“Proposal 2: The Company’s stockholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers, as disclosed in the Proxy Statement, by the votes set forth in the table below: For Against Abstain Broker Non-Votes 84,511,953 8,901,691 2,334,071 35,211,213”

Ovid Therapeutics Inc. shareholders approved Election of director Jeremy M. Levin, DPhil, MB BChir for a three-year term at the 2026-06-10 meeting.

“Proposal 1 : The Company’s stockholders elected the nominee for director to serve a three-year term until the Company’s 2029 annual meeting of stockholders and until his successor has been duly elected and qualified, or, if sooner, until his death, resignation or removal, by the votes set forth in the table below: Nominee For Withheld Broker Non-Votes Jeremy M. Levin, DPhil, MB BChir 87,219,707 8,528,008 35,211,213”

NXP Semiconductors N.V. shareholders approved Frequency of future advisory votes on Named Executive Officer compensation at the 2026-06-10 meeting.

“11. Approval on a non-binding, advisory basis of the frequency of future shareholder advisory votes on Named Executive Officer compensation. 1 Year 2 Years 3 Years Abstain 201,133,578 37,624 2,641,949 115,335”

NXP Semiconductors N.V. shareholders approved Non-binding advisory approval of Named Executive Officer compensation at the 2026-06-10 meeting.

“10. Approval on a non-binding, advisory basis of the compensation of our Named Executive Officers. For Against Abstain Broker Non-Votes 191,435,096 11,593,526 899,864 —”